Welcure Share Price Hits 5% Upper Circuit After Securing ₹517 Crore Global Sourcing Mandate

Welcure Drugs & Pharmaceuticals Ltd witnessed a sharp surge in its share price on 18 June 2025, hitting the 5% upper circuit. The rally came after the company announced a significant ₹517 crore global sourcing mandate with a Thailand-based client, marking a strategic expansion of its fee-based service portfolio without adding pressure to its balance sheet.

₹517 Crore Global Sourcing Mandate Secured

Welcure Drugs & Pharmaceuticals Ltd has announced the signing of a definitive third-party sourcing and procurement mandate valued at approximately ₹517 crore. The agreement is with Fortune Sagar Impex Company Limited, an overseas client based in Thailand. This marks a strategic addition to Welcure’s fee-based service portfolio under the ex-works model.

Revenue Potential of ₹25.85 Crore From Commission

Under the terms of the mandate, Welcure will earn a fixed 5% commission on the cost of goods sourced. This is expected to generate service income of around ₹25.85 crore, which will be recognised over the financial year 2025–26. The company clarified that the agreement enhances revenue without increasing balance sheet exposure.

Execution Timeline Extends To September 2026

The execution of this mandate will be carried out on a call-off basis. Mobilisation of the first batch will commence after the customary prefunding milestones are met. The entire sourcing activity is expected to conclude by September 30, 2026. This phased approach ensures operational flexibility and scalability.

Operational Responsibility Lies With The Buyer

As per the agreement, all post-procurement responsibilities, including packaging, labelling, containerisation, insurance, freight, and destination-country regulatory clearances, will be managed by the buyer, Fortune Sagar Impex. This allows Welcure to focus strictly on its core sourcing function.

Welcure Share Price Hit Upper Circuit of 5% 

Following the announcement of the ₹517 crore mandate, Welcure’s share price hit the upper circuit of 5%, reaching ₹13.74 as of 2:17 PM on June 18, 2025.

Read More: Samvardhana Motherson Shares in Focus; Announces 1:2 Bonus Issue and Final Dividend! 

Conclusion 

The ₹517 crore sourcing mandate represents a notable development in Welcure’s business strategy, strengthening its international presence and enhancing its fee-based income stream. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.